| Trial ID: | L0941 |
| Source ID: | NCT01556113
|
| Associated Drug: |
Omega-3 Fatty Acids
|
| Title: |
The Genetic Effect on Omega 3 Fatty Acid Supplementation for the Treatment of Non Alcoholic Fatty Liver Disease in Obese Children and Adolescents
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease;Steatohepatitis;Hypertriglyceridemia;Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1;Non Alcoholic Fatty Liver Disease;Steatohepatitis;Hypertriglyceridemia;Alanine Aminotransferase, Plasma Level of,
|
| Interventions: |
Other: Omega diet;Other: Omega diet;Other: Omega diet;Other: Omega diet
|
| Outcome Measures: |
reduction in hepatic fat fraction;reduction in hepatic fat fraction;reduction in hepatic fat fractionreduction in triglycerides;lower ALT levels
|
| Sponsor/Collaborators: |
Yale University
|
| Gender: |
All
|
| Age: |
10 Years19 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
17
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
12/03/2012
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
United States;United States;United States;United States;United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01556113
|
